CN105662654A - Coronary artery protecting device - Google Patents
Coronary artery protecting device Download PDFInfo
- Publication number
- CN105662654A CN105662654A CN201610105080.6A CN201610105080A CN105662654A CN 105662654 A CN105662654 A CN 105662654A CN 201610105080 A CN201610105080 A CN 201610105080A CN 105662654 A CN105662654 A CN 105662654A
- Authority
- CN
- China
- Prior art keywords
- coronary artery
- protection device
- isolation
- fixing
- coronary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004351 coronary vessel Anatomy 0.000 title claims abstract description 96
- 210000000709 aorta Anatomy 0.000 claims abstract description 26
- 210000003484 anatomy Anatomy 0.000 claims abstract description 6
- 238000002955 isolation Methods 0.000 claims description 41
- 238000005452 bending Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 4
- 230000003068 static effect Effects 0.000 claims description 2
- 230000008602 contraction Effects 0.000 claims 1
- 210000001765 aortic valve Anatomy 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000002093 peripheral effect Effects 0.000 abstract description 3
- 208000027896 Aortic valve disease Diseases 0.000 abstract description 2
- 208000001778 Coronary Occlusion Diseases 0.000 abstract description 2
- 206010011086 Coronary artery occlusion Diseases 0.000 abstract description 2
- 238000002513 implantation Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000010146 3D printing Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000003291 sinus of valsalva Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000032750 Device leakage Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 206010002906 aortic stenosis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010147 laser engraving Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000005036 potential barrier Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种冠状动脉保护装置,尤其涉及一种用于经导管转动脉瓣置换术的冠状动脉保护装置。The invention relates to a coronary artery protection device, in particular to a coronary artery protection device for transcatheter arterial valve replacement.
背景技术Background technique
经导管主动脉瓣置换术(TAVR,transcatheteraorticvalvereplacement)是目前心血管介入的热门新技术,该技术是通过外周动脉送入介入导管,通过介入导管将压缩的人工心脏瓣膜输送至主动脉瓣区打开,从而完成人工瓣膜置入,恢复瓣膜功能的,是一种微创的置入人工心脏瓣膜的方式。该技术的侵入性小于开心手术,因而大大降低了心脏外科手术的风险,患者的术后恢复时间也大大缩短,目前在国际上已成为主动脉瓣狭窄患者的一线治疗方案。TAVR前景目前被普遍看好,预计到2025年,全球每年完成TAVR手术量将达30万例左右。Transcatheter aortic valve replacement (TAVR, transcatheteraorticvalvereplacement) is a popular new technology for cardiovascular intervention. This technology is to send the interventional catheter through the peripheral artery, and deliver the compressed artificial heart valve to the aortic valve area through the interventional catheter. It is a minimally invasive way to insert an artificial heart valve to complete the implantation of the artificial valve and restore the function of the valve. The technique is less invasive than open-heart surgery, thus greatly reducing the risk of cardiac surgery and shortening postoperative recovery time for patients. It has become the first-line treatment for patients with aortic stenosis internationally. The prospect of TAVR is currently generally optimistic. It is estimated that by 2025, the number of TAVR operations performed globally will reach about 300,000 cases per year.
但是,该技术目前仍是一种高危的手术,可导致致命的并发症。冠状动脉堵塞是其中一种死亡率极高的并发症,可引起急性心肌梗死、心源性休克而致死。其主要机制是自体主动脉脉瓣膜上翻堵住冠状动脉开口。此外,瓣膜支架放置过高,使得介入瓣膜裙边挡住冠脉开口,也可引起冠脉阻塞及心肌梗死。因此,TAVR术前应评估主动脉根部的解剖结构,包括瓦氏窦宽度(应比瓣膜型号大3mm以上)、瓦氏窦高度(应>15mm)以及冠状动脉高度(应>12mm)。但是如果按照此标准进行病例筛选,将有1/4的病例被排除在外而无法接受TAVR手术。此外,即使完全按照此标准进行TAVR手术,仍有少数病例可能发生冠脉堵塞。因此,研发用于TAVR术冠状动脉保护的装置,使得诸多的主动脉根部条件不符合条件患者也能行TAVR术,具有巨大社会效益和市场需求。However, the technique is currently still a high-risk procedure that can lead to fatal complications. Coronary artery blockage is one of the complications with a high mortality rate, which can cause acute myocardial infarction, cardiogenic shock and death. The main mechanism is that the native aortic valve overturns to block the coronary artery opening. In addition, the valve stent is placed too high, so that the skirt of the interventional valve blocks the coronary artery opening, which can also cause coronary artery obstruction and myocardial infarction. Therefore, the anatomical structure of the aortic root should be evaluated before TAVR, including the width of the sinus of Valsalva (should be more than 3 mm larger than the valve size), the height of the sinus of Valsalva (should be >15 mm), and the height of the coronary arteries (should be >12 mm). However, if the case screening is carried out according to this standard, 1/4 of the cases will be excluded and cannot receive TAVR surgery. In addition, even if TAVR is performed in full accordance with this standard, coronary artery blockage may still occur in a small number of cases. Therefore, the development of a device for coronary artery protection in TAVR allows many patients with unqualified aortic root conditions to undergo TAVR, which has huge social benefits and market demand.
发明内容Contents of the invention
有鉴于现有技术的上述缺陷,本发明所要解决的技术问题是如何为TAVR术提供冠状动脉的保护,避免TAVR引起冠状动脉堵塞的风险。In view of the above-mentioned defects in the prior art, the technical problem to be solved by the present invention is how to provide coronary artery protection for TAVR and avoid the risk of coronary artery blockage caused by TAVR.
为实现上述目的,本发明提供了一种冠状动脉保护装置,该装置也是经外周动脉途径植入升主动脉和冠状动脉的结合处的,在经导管主动脉瓣置换之前植入,可保障TAVR术中和术后冠状动脉血流的通畅,避免冠状动脉闭塞并发症的发生,使得升主动脉根部解剖结构不符合目前标准的主动脉瓣疾病患者实现经导管主动脉瓣的置换。In order to achieve the above object, the present invention provides a coronary artery protection device, which is also implanted at the junction of the ascending aorta and the coronary artery through the peripheral artery, and is implanted before transcatheter aortic valve replacement, which can guarantee TAVR Unobstructed coronary blood flow during and after the operation, avoiding the occurrence of coronary occlusion complications, and enabling transcatheter aortic valve replacement in patients with aortic valve disease whose anatomical structure of the ascending aortic root does not meet the current standards.
本发明提供的冠状动脉保护装置包括用于将潜在的阻挡物与冠状动脉开口隔离的隔离部件和用于固定该隔离部件位置的固定部件,该隔离部件与该固定部件相互连接在一起;该隔离部件的工作位置为升主动脉根部与冠状动脉的结合处。其中,所述潜在的阻挡物可以是上翻的自体主动脉脉瓣膜、介入瓣膜裙边或其它任何可能会造成冠状动脉堵塞的物件。The coronary artery protection device provided by the present invention includes an isolation component for isolating potential barriers from the coronary artery opening and a fixing component for fixing the position of the isolation component, and the isolation component and the fixing component are connected to each other; the isolation The working position of the component is the junction of the root of the ascending aorta and the coronary arteries. Wherein, the potential obstacle may be an upturned native aortic valve, a skirt of an intervening valve, or any other object that may cause coronary artery blockage.
该冠状动脉保护装置可在径向扩张的第一形态和径向收缩的第二形态之间变换;其中,所述第一形态为该装置被植入人体升主动脉根部与冠状动脉结合处的预定位置后的工作形态,所述第二形态为该装置被经导管输送时的输送形态。The coronary artery protection device can be transformed between a radially expanded first configuration and a radially contracted second configuration; wherein, the first configuration is that the device is implanted at the junction of the root of the ascending aorta and the coronary artery in the human body. The working configuration after the predetermined position, the second configuration is the delivery configuration when the device is delivered through the catheter.
进一步,所述第二形态为细条状,使之能够装载于一定内径的长条状输送鞘管内,从体外沿着人体动脉送到升主动脉根部。Further, the second form is in the shape of a thin strip, so that it can be loaded in a long strip-shaped delivery sheath with a certain inner diameter, and sent from the outside of the body along the human artery to the root of the ascending aorta.
优选地,该隔离部件具有网格结构,不会影响血液的流动;进一步优选地,该隔离部件为管状,血液能从周围流入该隔离部件的内腔;更进一步,该管状隔离部件的工作状态为沿升主动脉的轴向排布。Preferably, the isolation part has a grid structure, which will not affect the flow of blood; further preferably, the isolation part is tubular, and blood can flow into the lumen of the isolation part from the surrounding; further, the working state of the tubular isolation part It is arranged axially along the ascending aorta.
优选地,该固定部件的工作位置为冠状动脉内,该固定部件通过与冠状动脉壁之间的静摩擦力来固定该冠状动脉保护装置的位置,以防止整个装置移位脱落;进一步优选地,该固定部件为具有网格结构的管状;在这种情况下,其第一形态的截面直径应适合冠状动脉的内径,以比冠状动脉内径略大为佳,通常优选为2-5mm;优选地,该固定部件的长度为2-6cm,所述长度也即该固定部件进入冠状动脉的深度。Preferably, the working position of the fixing component is inside the coronary artery, and the fixing component fixes the position of the coronary artery protection device through static friction with the coronary artery wall, so as to prevent the entire device from shifting and falling off; further preferably, the The fixing part is tubular with a grid structure; in this case, the cross-sectional diameter of its first form should be suitable for the inner diameter of the coronary artery, preferably slightly larger than the inner diameter of the coronary artery, usually preferably 2-5mm; preferably, The length of the fixing component is 2-6 cm, and the length is the depth at which the fixing component enters the coronary artery.
优选地,所述管状为圆管状或椭圆管状,该结构具有较强的支撑力,不易变形;对于隔离部件,当介入瓣膜被植入升主动脉中后会对该隔离部件产生压迫作用,较强的支撑力能保持管体内血流的通畅;对于固定部件,较强的支撑力可产生更好的摩擦作用从而更牢固地固定,且也能保持管体内血流的通畅。Preferably, the tubular shape is circular or elliptical, and this structure has a strong supporting force and is not easily deformed; as for the isolation component, when the interventional valve is implanted in the ascending aorta, it will have a compressive effect on the isolation component, which is relatively The strong supporting force can keep the blood flow in the tube unobstructed; for the fixed parts, the strong supporting force can produce better friction effect so as to be more firmly fixed, and can also keep the blood flow in the tube unobstructed.
优选地,所述网格结构为菱形网格结构,该结构可进一步提高支撑力;构成隔离部件网格结构的网格线可以比固定部件的网格线略粗,因为隔离部件需要更强的支撑力。Preferably, the grid structure is a rhombus grid structure, which can further improve the supporting force; the grid lines constituting the grid structure of the isolation parts can be slightly thicker than the grid lines of the fixed parts, because the isolation parts need stronger support.
优选地,所述隔离部件的直径为4-8mm,所述隔离部件的长度为5-15cm。Preferably, the diameter of the isolation part is 4-8 mm, and the length of the isolation part is 5-15 cm.
在本发明的一种优选实施方式中,所述隔离部件与所述固定部件为一体化的管状,中间具有弯折角,即该冠状动脉保护装置在第一形态时自身会形成一个弯折角,该弯折角的范围优选为60°~150°,进一步该弯折角为圆角,不具有尖锐而容易造成机械损害的外轮廓。In a preferred embodiment of the present invention, the isolation member and the fixing member are in an integrated tubular shape with a bending angle in the middle, that is, the coronary artery protection device itself forms a bending angle in the first form, the The bending angle preferably ranges from 60° to 150°, furthermore, the bending angle is rounded and does not have a sharp outer contour that is likely to cause mechanical damage.
升主动脉壁连有左冠状动脉和右冠状动脉,在本发明的一种优选实施方式中,所述隔离部件的工作位置从冠状动脉的开口处向上延伸,贴靠升主动脉根部一侧(左或右)的内壁,且其高度高于即将植入的介入瓣膜的高度,于是就在该侧的升主动脉至冠状动脉开口之间架设了一条血液流通的通道,可保证冠状动脉血流的畅通。The wall of the ascending aorta is connected with the left coronary artery and the right coronary artery. In a preferred embodiment of the present invention, the working position of the isolation member extends upwards from the opening of the coronary artery and abuts against the root of the ascending aorta ( left or right), and its height is higher than the height of the interventional valve to be implanted, so a blood circulation channel is set up between the ascending aorta on this side and the coronary artery opening to ensure coronary blood flow unimpeded.
优选地,该隔离部件的第一形态的远心端开口较大,容易进入导管和导丝,有利于日后的冠状动脉介入治疗;该隔离部件的第一形态的近心端截面直径可等于或大于固定部件的最大截面直径。在本发明的一种优选实施方式中,该隔离部件的形状优选为沿管状的轴向向远心端逐渐增大的喇叭状。Preferably, the opening of the distal end of the first form of the isolating part is relatively large, and it is easy to enter catheters and guide wires, which is conducive to future coronary intervention; the cross-sectional diameter of the proximal end of the first form of the isolating part can be equal to or greater than the maximum cross-sectional diameter of the fixed part. In a preferred embodiment of the present invention, the shape of the isolation member is preferably a trumpet shape gradually increasing toward the distal end along the axial direction of the tube.
左冠状动脉和右冠状动脉为心脏提供血流,保障心脏的供血、供氧,所述固定部件由升主动脉壁上的左/右冠状动脉开口处进入左/右冠状动脉内。由于左、右冠状动脉的结构会有小差异,因此本发明的固定部件的形态可按左/右冠状动脉的走形设计,径向截面的直径略大于冠状动脉的内径;进一步隔离部件也可按左/右冠状动脉与升主动脉之间的走形设计;更进一步,本发明的冠状动脉保护装置可根据个体差异作个性化设计,以满足不同人群的不同的需求。The left coronary artery and the right coronary artery provide blood flow to the heart to ensure the blood supply and oxygen supply of the heart. The fixing part enters the left/right coronary artery from the opening of the left/right coronary artery on the wall of the ascending aorta. Because the structures of the left and right coronary arteries have small differences, the shape of the fixing part of the present invention can be designed according to the shape of the left/right coronary arteries, and the diameter of the radial section is slightly larger than the inner diameter of the coronary arteries; further isolation parts can also be It is designed according to the shape between the left/right coronary artery and the ascending aorta; furthermore, the coronary artery protection device of the present invention can be individually designed according to individual differences to meet the different needs of different groups of people.
本发明所述“远心端”是指所述装置被植入升主动脉根部与冠状动脉的结合处预定位置后远离心脏的一端,“近心端”是指所述装置被植入升主动脉根部与冠状动脉的结合处预定位置后靠近心脏的一端。The "distal end" in the present invention refers to the end far away from the heart after the device is implanted at the junction of the root of the ascending aorta and the coronary artery. The end near the heart behind the predetermined position where the arterial root joins the coronary arteries.
优选地,所述冠状动脉保护装置的总长为10-20cm。Preferably, the total length of the coronary artery protection device is 10-20cm.
优选地,所述冠状动脉保护装置由一体化3D打印制成。Preferably, the coronary artery protection device is made by integrated 3D printing.
在本发明的一种优选实施方式中,所述冠状动脉保护装置由自膨胀材料构成,在体外可以压缩成条状的第二形态,在体内释放后可以自动恢复到第一形状。在本发明的另一种优选实施方式中,该装置也可以球囊扩张原理进行释放,装置在体外压缩成条状的第二形态,负载在球囊外面,到达体内后扩张球囊释放装置,使得装置恢复到第一形态。In a preferred embodiment of the present invention, the coronary artery protection device is made of a self-expanding material, which can be compressed into a strip-like second shape outside the body, and can automatically return to the first shape after being released in vivo. In another preferred embodiment of the present invention, the device can also be released by the principle of balloon expansion. The device is compressed into a strip-like second shape outside the body, loaded on the outside of the balloon, and expanded after reaching the body. Returning the device to the first configuration.
优选地,所述冠状动脉保护装置由金属材料制成;进一步优选为具有温度记忆的镍钛合金材料。Preferably, the coronary artery protection device is made of a metal material; more preferably, it is a nickel-titanium alloy material with temperature memory.
在本发明的一个优选实施例中,所述冠状动脉保护装置为一体化的圆管,具有网格结构,可在径向扩张的第一形态和径向收缩的第二形态之间变换,其第一形态具有弯折角,该弯折角的一侧为隔离部件,用于将潜在的阻挡物与冠状动脉开口隔离,该弯折角的另一侧为固定部件,用于固定该隔离部件的位置,所述一体化的圆管的第一形态接近于人体升主动脉根部和冠状动脉结合处的解剖结构。In a preferred embodiment of the present invention, the coronary artery protection device is an integrated circular tube with a grid structure, which can be transformed between a radially expanded first form and a radially contracted second form, which The first form has a bending angle, one side of the bending angle is an isolation component, which is used to isolate the potential obstruction from the coronary artery opening, and the other side of the bending angle is a fixing component, which is used to fix the position of the isolation component, The first shape of the integrated circular tube is close to the anatomical structure of the junction of the root of the ascending aorta and the coronary artery in the human body.
本发明是根据心脏解剖特征和经导管主动脉瓣置换技术原理而发明的:经导管主动脉瓣置换时,所植入的介入瓣膜充分扩张后,可能使得自体的主动脉瓣膜被挤压上翻,堵塞冠状动脉开口,介入瓣膜的裙边也可能堵塞冠状动脉开口,该保护装置被植入后,可在介入瓣膜的外侧的升主动脉至冠状动脉开口之间撑开一条隧道,保证血流由升主动脉流入冠状动脉;另一方面,保护装置的形态符合主动脉根部解剖特点,能良好的固定而不脱位;本装置位于自体瓣环之上、介入瓣膜之外,故不会影响介入瓣膜的功能和固定作用,不会导致瓣周漏和瓣膜反流。The present invention is invented based on the anatomical characteristics of the heart and the technical principle of transcatheter aortic valve replacement: during transcatheter aortic valve replacement, after the implanted interventional valve is fully expanded, the native aortic valve may be squeezed upwards , block the coronary artery opening, and the skirt of the interventional valve may also block the coronary artery opening. After the protective device is implanted, a tunnel can be opened between the ascending aorta on the outside of the interventional valve and the coronary artery opening to ensure blood flow. It flows into the coronary artery from the ascending aorta; on the other hand, the shape of the protective device conforms to the anatomical characteristics of the aortic root, and can be fixed well without dislocation; the device is located above the native valve annulus and outside the interventional valve, so it will not affect the intervention The function and fixation of the valve will not lead to paravalvular leak and valvular regurgitation.
本发明具有以下有益技术效果:The present invention has the following beneficial technical effects:
①操作作简单:本发明的体内植入过程与目前的冠脉支架植入过程相同,手术操作相对简单。①Simple operation: the implantation process in the body of the present invention is the same as that of the current coronary stent implantation, and the operation is relatively simple.
②制作简单、成熟:本发明的基本材料可采用常规的冠脉、血管支架材料,制作方法也可采用目前常规的支架制作方法,故制作相对简单、成熟。②Simple and mature production: the basic material of the present invention can be conventional coronary artery and vascular stent materials, and the production method can also adopt the current conventional stent production method, so the production is relatively simple and mature.
③安全性高:该装置植入时和植入后,都不影响冠状动脉的供血,不影响人体瓣膜或者介入瓣膜的功能。③ High safety: The device will not affect the blood supply of the coronary arteries during and after implantation, and will not affect the function of human valves or interventional valves.
④不影响冠脉介入治疗:隔离部件的开口较大,成喇叭状,容易进入导丝和导管,万一患者日后发生冠状动脉病变,不影响其介入治疗。④ Does not affect coronary interventional therapy: The opening of the isolation part is large and trumpet-shaped, which is easy to enter the guide wire and catheter. In case of coronary artery disease in the patient in the future, the interventional therapy will not be affected.
以下将结合附图对本发明的构思、具体结构及产生的技术效果作进一步说明,以充分地了解本发明的目的、特征和效果。The idea, specific structure and technical effects of the present invention will be further described below in conjunction with the accompanying drawings, so as to fully understand the purpose, features and effects of the present invention.
附图说明Description of drawings
图1是本发明的一个较佳实施例的第一形态立体结构示意图;Fig. 1 is a schematic diagram of a first form three-dimensional structure of a preferred embodiment of the present invention;
图2是图1中较佳实施例的立体俯视图;Fig. 2 is a perspective top view of the preferred embodiment in Fig. 1;
图3是本发明的工作位置解剖结构示意图。Fig. 3 is a schematic diagram of the anatomical structure of the working position of the present invention.
具体实施方式detailed description
如图1所示为本发明的一个较佳实施例的第一形态的结构示意图。该冠状动脉保护装置为具有网格结构的管状,包括隔离部件1和固定部件2,该装置的各部件之间可采用常规的连接方式连接,也可以采用一体成型的方式制作而成。As shown in FIG. 1 , it is a schematic structural diagram of a first form of a preferred embodiment of the present invention. The coronary artery protection device is tubular with a grid structure and includes an isolation part 1 and a fixing part 2. The parts of the device can be connected by conventional connection methods, or can be made by integral molding.
本实施例中,隔离部件1与固定部件2为一体化的圆管,其第一形态如图中所示类似于字母L型,该圆管具有菱形的网格结构,隔离部件1与固定部件2之间形成弯折的圆角α,α的大小以隔离部件1的中轴线和固定部件2的中轴线的夹角来确定,优选为60°~150°;隔离部件1的网格线比固定部件2的网格线略粗,可以提供更大的支撑力。In this embodiment, the isolating part 1 and the fixing part 2 are an integrated circular tube, and its first shape is similar to the letter L as shown in the figure. The round tube has a rhombus grid structure, and the isolating part 1 and the fixing part 2 to form a bent round angle α, the size of α is determined by the angle between the central axis of the isolation component 1 and the central axis of the fixed component 2, preferably 60° to 150°; the grid line ratio of the isolation component 1 The grid lines of the fixed part 2 are slightly thicker, which can provide greater support.
本发明的结构不只局限于L型管状,任意能实现隔离和固定功能的结构都是可行的,如T型管状、I型管状等;本发明的网格形状也不唯一,任意能满足血流流通和收缩扩张要求的形状都是可行的。The structure of the present invention is not limited to the L-shaped tubular shape, any structure that can realize isolation and fixation functions is feasible, such as T-shaped tubular shape, I-shaped tubular shape, etc.; the grid shape of the present invention is not unique, and any structure that can satisfy blood flow Both flow-through and shrink-expand shapes are available.
如图2所示,本实施例的隔离部件1为喇叭状的圆管,沿管状的轴向向远心端逐渐增大,其工作位置如图3所示,贴靠升主动脉根部的内壁,自冠状动脉开口向上排布;固定部件的工作位置在冠状动脉内。当介入瓣膜3植入后会对该隔离部件1产生径向的压迫作用,本实施例中的隔离部件1则具有较强的支撑力,能保持管体内血流的通畅,使血流能顺利地流入冠状动脉内。As shown in Figure 2, the isolation member 1 of this embodiment is a trumpet-shaped round tube, which gradually increases toward the distal end along the axial direction of the tube, and its working position is shown in Figure 3, abutting against the inner wall of the root of the ascending aorta , arranged upwards from the opening of the coronary artery; the working position of the fixing part is inside the coronary artery. When the interventional valve 3 is implanted, it will exert radial pressure on the isolation part 1. The isolation part 1 in this embodiment has a strong supporting force, which can keep the blood flow in the tube unobstructed, so that the blood flow can be smooth. into the coronary arteries.
本发明的外部轮廓线与升主动脉根部及冠状动脉近段的走形一致。本发明可以根据需要设计成左冠状动脉型和右冠状动脉型两种类型,固定部件的长度为2-6cm,内径与比人体左右冠状动脉的内径稍大,支撑力可接近目前现有的冠脉支架,以免损伤冠状动脉,且可根据个体差异设计个性化参数,以符合不同人体不同冠状动脉内径的需求。The outer contour line of the present invention is consistent with the shape of the root of the ascending aorta and the proximal section of the coronary artery. The present invention can be designed into two types of left coronary artery type and right coronary artery type according to needs, the length of the fixing part is 2-6cm, the inner diameter is slightly larger than the inner diameter of the left and right coronary arteries of the human body, and the supporting force can be close to the existing coronary arteries. Artery stents to avoid damage to coronary arteries, and individual parameters can be designed according to individual differences to meet the needs of different coronary artery diameters in different people.
隔离部件的长度为5-15cm,近心端直径可等于或者大于固定部件的直径,远心端的直径逐渐扩大,呈喇叭状开口。隔离部件的径向支撑力较大,可以对抗介入瓣膜的压迫,在介入瓣膜压迫下,仍可保持圆管状或椭圆管状形态,保证隔离部件内有管腔空间连向固定部件。The length of the isolation part is 5-15 cm, the diameter of the proximal end can be equal to or greater than the diameter of the fixed part, and the diameter of the distal end gradually expands to form a trumpet-shaped opening. The radial support force of the isolation part is relatively large, which can resist the pressure of the interventional valve. Under the pressure of the interventional valve, it can still maintain a circular tubular or elliptical tubular shape, ensuring that there is a lumen space in the isolation part connected to the fixed part.
本实施例装置的第一形态整体上接近L型,但是,隔离部件1和固定部件2之间由平滑的圆角过渡,一体连接,无锐角,以免植入时损伤人体组织,且该圆角的角度依据冠状动脉和升主动脉的夹角设计,使得本实施例装置植入人体后能自然贴合于升主动脉内壁。The first form of the device of this embodiment is generally close to L-shaped, but the spacer part 1 and the fixing part 2 are connected by a smooth rounded transition, without sharp corners, so as not to damage human tissue during implantation, and the rounded corners The angle is designed according to the included angle between the coronary artery and the ascending aorta, so that the device of this embodiment can be naturally attached to the inner wall of the ascending aorta after being implanted in the human body.
该装置可在扩张的第一形态和收缩的第二形态之间变换,第一形态为该装置被植入人体升主动脉根部与冠状动脉结合处的预定位置后的工作形态,第二形态为该装置被经导管输送时的输送形态。本实施例采用自膨胀或者球囊扩张膨胀的原理,在体外,该装置可以被压迫成条状,放置于输送系统中,到达主动脉根部预定位置后,通过自膨胀或者球囊扩张,可以恢复到原始设计的形态且具有较高的硬度,并通过固定部件的作用牢牢固定于升主动脉根部的预定位置中。The device can be transformed between the expanded first form and the contracted second form. The first form is the working form after the device is implanted at the predetermined position at the junction of the root of the ascending aorta and the coronary artery of the human body. The second form is The delivery configuration of the device as it is delivered through the catheter. This embodiment adopts the principle of self-expansion or balloon expansion. In vitro, the device can be compressed into strips and placed in the delivery system. After reaching the predetermined position of the aortic root, it can be restored by self-expansion or balloon expansion. It has the shape of the original design and has high hardness, and is firmly fixed in the predetermined position of the root of the ascending aorta through the action of the fixing component.
本实施例的冠状动脉保护装置的制作方法优选为激光雕刻技术,但该制备方法不唯一,在其它的优选实施方式中也可以采用一体成型的3D打印技术制作。The manufacturing method of the coronary artery protection device in this embodiment is preferably laser engraving technology, but this manufacturing method is not unique, and in other preferred embodiments, it can also be manufactured by integrally formed 3D printing technology.
本发明的冠状动脉保护装置在实际植入时可采用以下步骤:The coronary artery protection device of the present invention can adopt the following steps during actual implantation:
(1)在体外,使用压迫器械,将所述装置迫成细条状后,再将其置入输送系统的鞘管中;(1) outside the body, use a compression device to force the device into a thin strip, and then place it into the sheath of the delivery system;
(2)将导丝从升主动脉路径插入冠状动脉中,沿着导丝将装有装置的输送鞘管送至冠状动脉内;(2) Insert the guide wire into the coronary artery from the ascending aorta, and send the delivery sheath equipped with the device into the coronary artery along the guide wire;
(3)后撤输送鞘管,打开装置;(3) Withdraw the delivery sheath and open the device;
(4)完全释放装置,退出输送系统。(4) Release the device completely and exit the delivery system.
上述植入步骤以及植入后不会影响患者自身的主动脉瓣功能,也不影响冠脉血流,植入后不影响介入瓣膜的功能,同时又能在介入瓣膜植入后起到保护冠状动脉的作用,避免冠状动脉开口被堵塞。The above implantation steps and after implantation will not affect the function of the patient's own aortic valve, nor will it affect the coronary blood flow. After implantation, the function of the interventional valve will not be affected, and at the same time, it can protect the coronary artery The role of arteries to prevent coronary artery openings from being blocked.
以上详细描述了本发明的较佳具体实施例。应当理解,本领域的普通技术人员无需创造性劳动就可以根据本发明的构思作出诸多修改和变化。因此,凡本技术领域中技术人员依本发明的构思在现有技术的基础上通过逻辑分析、推理或者有限的实验可以得到的技术方案,皆应在由权利要求书所确定的保护范围内。The preferred specific embodiments of the present invention have been described in detail above. It should be understood that those skilled in the art can make many modifications and changes according to the concept of the present invention without creative efforts. Therefore, all technical solutions that can be obtained by those skilled in the art based on the concept of the present invention through logical analysis, reasoning or limited experiments on the basis of the prior art shall be within the scope of protection defined by the claims.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610105080.6A CN105662654A (en) | 2016-02-25 | 2016-02-25 | Coronary artery protecting device |
CN201720161187.2U CN207627445U (en) | 2016-02-25 | 2017-02-22 | A kind of coronary artery protective device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610105080.6A CN105662654A (en) | 2016-02-25 | 2016-02-25 | Coronary artery protecting device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105662654A true CN105662654A (en) | 2016-06-15 |
Family
ID=56305148
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610105080.6A Pending CN105662654A (en) | 2016-02-25 | 2016-02-25 | Coronary artery protecting device |
CN201720161187.2U Active CN207627445U (en) | 2016-02-25 | 2017-02-22 | A kind of coronary artery protective device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201720161187.2U Active CN207627445U (en) | 2016-02-25 | 2017-02-22 | A kind of coronary artery protective device |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN105662654A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108309505A (en) * | 2017-10-13 | 2018-07-24 | 杭州启明医疗器械有限公司 | Thrombus protective device |
CN111132636A (en) * | 2017-09-27 | 2020-05-08 | W.L.戈尔及同仁股份有限公司 | Prosthetic valves with expandable frames and associated systems and methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101172055A (en) * | 2006-09-28 | 2008-05-07 | 贝鲁斯研制厂 | Implant for placing in a blood vessel |
WO2010026240A1 (en) * | 2008-09-04 | 2010-03-11 | Karolinska Institutet Innovations Ab | Temporary embolic protection device and medical procedure for delivery thereof |
WO2010081025A1 (en) * | 2009-01-09 | 2010-07-15 | Embrella Cardiovascular, Inc. | Embolic deflection device and method of use |
CN102014791A (en) * | 2008-02-22 | 2011-04-13 | 巴兹和伦敦全民健康医疗服务基金会 | Blood vessel prosthesis and delivery apparatus |
CN102670333A (en) * | 2012-06-08 | 2012-09-19 | 同济大学 | Aortic valve stent with coronary artery and conveyor of same |
WO2013036168A1 (en) * | 2011-09-06 | 2013-03-14 | Закрытое Акционерное Общество Научно-Производственное Предприятие "Мединж" | Valved aortic root prosthesis |
CN103945793A (en) * | 2011-12-06 | 2014-07-23 | 俄奥梯科创新有限公司 | Device for endovascular aortic repair and method of using the same |
-
2016
- 2016-02-25 CN CN201610105080.6A patent/CN105662654A/en active Pending
-
2017
- 2017-02-22 CN CN201720161187.2U patent/CN207627445U/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101172055A (en) * | 2006-09-28 | 2008-05-07 | 贝鲁斯研制厂 | Implant for placing in a blood vessel |
CN102014791A (en) * | 2008-02-22 | 2011-04-13 | 巴兹和伦敦全民健康医疗服务基金会 | Blood vessel prosthesis and delivery apparatus |
WO2010026240A1 (en) * | 2008-09-04 | 2010-03-11 | Karolinska Institutet Innovations Ab | Temporary embolic protection device and medical procedure for delivery thereof |
WO2010081025A1 (en) * | 2009-01-09 | 2010-07-15 | Embrella Cardiovascular, Inc. | Embolic deflection device and method of use |
WO2013036168A1 (en) * | 2011-09-06 | 2013-03-14 | Закрытое Акционерное Общество Научно-Производственное Предприятие "Мединж" | Valved aortic root prosthesis |
CN103945793A (en) * | 2011-12-06 | 2014-07-23 | 俄奥梯科创新有限公司 | Device for endovascular aortic repair and method of using the same |
CN102670333A (en) * | 2012-06-08 | 2012-09-19 | 同济大学 | Aortic valve stent with coronary artery and conveyor of same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111132636A (en) * | 2017-09-27 | 2020-05-08 | W.L.戈尔及同仁股份有限公司 | Prosthetic valves with expandable frames and associated systems and methods |
CN111132636B (en) * | 2017-09-27 | 2022-04-08 | W.L.戈尔及同仁股份有限公司 | Prosthetic valves with expandable frames and associated systems and methods |
CN108309505A (en) * | 2017-10-13 | 2018-07-24 | 杭州启明医疗器械有限公司 | Thrombus protective device |
Also Published As
Publication number | Publication date |
---|---|
CN207627445U (en) | 2018-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230233318A1 (en) | Modular valve prosthesis with anchor stent and valve component | |
US20210077256A1 (en) | Stents for prosthetic heart valves | |
US10231832B2 (en) | Stents for prosthetic heart valves | |
US9456899B2 (en) | Transcatheter prosthetic heart valve post-dilatation remodeling devices and methods | |
US20170165053A1 (en) | Bowed Runners for Paravalvular Leak Protection | |
KR102563467B1 (en) | Pulmonary ball valve assembly via catheter | |
US12036113B2 (en) | Delivery of heart chamber prosthetic valve implant | |
JP2015177971A (en) | Heart valve for transplantation | |
BR102015024747B1 (en) | IMPLANTABLE DEVICE TO TREAT MITRAL VALVE REGURGITATION | |
CN102083391A (en) | Stented heart valve devices | |
CN104257442B (en) | Intrusive replacement valve and controllable conveying device thereof | |
CN207627445U (en) | A kind of coronary artery protective device | |
CN106073945B (en) | A kind of dystopy implantation valve bracket system for treating tricuspid regurgitation | |
CN113197709A (en) | Implant delivery device and implant delivery system | |
CN216221867U (en) | Valve support and artificial valve device comprising same | |
CN217987801U (en) | Implant conveying device and implant conveying system | |
CN114191146A (en) | Valve support and artificial valve device comprising same | |
CN221654698U (en) | Delivery catheter and implant delivery system | |
SAPIEN | Transcatheter Aortic Valve Implantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160615 |
|
WD01 | Invention patent application deemed withdrawn after publication |